<p>Avanos Medical Inc. has issued an amendment to its previously filed Form 8-K, clarifying that all 16,300 time-based restricted stock units granted to Mojirade James on April 22, 2025, vested in full on December 1, 2025, following the termination of her employment. All other disclosures in the initial report remain unchanged. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avanos Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001606498-25-000135), on December 05, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

AVNS

<p>Avanos Medical Inc. amended its Form 8-K to disclose that all 16,300 restricted stock units granted to Mojirade James vested fully on December 1, 2025, after her employment ended. Other disclosures remain unchanged.</p>

Avanos Medical Amends Report to Disclose Full Vesting of Restricted Stock Units for Departed Executive